Quoted Micro 22 August 2022
AQUIS STOCK EXCHANGE Invinity Energy Systems (IES) has signed a memorandum of understanding with US Vanadium to create a US-based 50/50 joint venture to build and sell vanadium flow batteries. Arkansas-based US Vanadium produces high-purity vanadium pentoxide and electrolyte for vanadium flow batteries. Invinity Energy Systems has also delivered and installed a 1.8MWh VS3 flow […]
Andrew Hore – Quoted Micro 27 December 2021
AQUIS STOCK EXCHANGE All Things Considered Group (ATC) is a music artist management and services provider that branched out into live streaming events due to Covid-19. There was £4.13m raised at 153p a share, and the share price rose to 155p, valuing the company at £15m. In the six months to June 2021, revenues jumped […]
Quoted Micro 20 December 2021
AQUIS STOCK EXCHANGE The ecommerce technology and brands retailer Samarkand Group (SMK) reported lower interim revenues because of a one-off PPE contract in the previous period. There was a small underlying dip in revenues to £7.17m as the wholesaling business is being run down to a less important level of operations. The two core parts […]
Andrew Hore – Quoted Micro 23 August 2021
AQUIS STOCK EXCHANGE Adnams (ADB) says that trading has improved since 17 May with strong demand for hotel accommodation. Interim revenues were flat at £20.5m, while the loss dipped from £3.87m to £3.34m. Net bank debt was £13.4m at the end of June 2021. GP software provider DXS International (DXSP) increased its full year revenues […]
Andrew Hore – Quoted Micro 9 August 2021
AQUIS STOCK EXCHANGE Chapel Down (CDGP) has announced Andrew Carter as successor to chief executive Frazer Thompson in September 2021. National Milk Records (NMRP) increased its fourth quarter revenues by 7% to £5.72m. Milk recording revenues grew by 9%. The corresponding period did cover the initial lockdown. Milk prices are holding up at levels where […]
Andrew Hore – Quoted Micro 14 June 2021
AQUIS STOCK EXCHANGE Clarify Pharma (PSYC) joined the Access segment on 11 June and raised £1.96m at 2.5p a share. Prior to flotation, Clarify Pharma raised £100,000 at 0.1p a share and £1.19m at 1p a share. Pro forma NAV, after flotation expenses, is £2.97m. That is equivalent to 1p a share. Management includes Michael […]